Chemists simplify the synthesis of antitumor compounds
Friday, January 31, 2020 - 10:30
in Physics & Chemistry
A RUDN chemist in collaboration with colleagues from N.D. Zelinsky Institute of Organic Chemistry and N.K. Koltsov Institute of Developmental Biology (IDB), RAS have developed a new method for the synthesis of isoxazole derivatives—substances that destabilize the process of cell division and potentially may become the basis for new anticancer drugs. The new method is based on the use of easily available reagents and does not require high temperatures. The work was published in European Journal of Organic Chemistry.